Bioxcel Therapeutics, Inc. (BTAI)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

6

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Sep-24 7:23 PM View:	16-Sep-24 Planned Option Sale ($0.24K)	Yocca Frank Chief Scientific Officer		Bioxcel Therapeutics, Inc. - BTAI	5% 13.47K to 14.2K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:20 PM View:	16-Sep-24 Planned Option Sale ($0.24K)	Rodriguez Javier See Remarks		Bioxcel Therapeutics, Inc. - BTAI	9% 8.39K to 9.13K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:18 PM View:	16-Sep-24 Planned Option Sale ($0.15K)	Wiley Matthew T. CHIEF COMMERCIAL OFFICER		Bioxcel Therapeutics, Inc. - BTAI	15% 3.5K to 4.03K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:21 PM View:	16-Sep-24 Planned Option Sale ($0.25K)	Steinhart Richard I Chief Financial Officer		Bioxcel Therapeutics, Inc. - BTAI	13% 5.48K to 6.2K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:19 PM View:	16-Sep-24 Planned Option Sale ($95.33)	O'Neill Vincent See Remarks		Bioxcel Therapeutics, Inc. - BTAI	11% 3.52K to 3.91K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:21 PM View:	16-Sep-24 Planned Option Sale ($1.37K)	Mehta Vimal CEO and President Director 10% Owner		Bioxcel Therapeutics, Inc. - BTAI	0% 7.74M to 7.74M	0	0	--	--	Show Txns Hide Txns